Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 114

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 114
---
 than those pertaining to income tax, are not addressed in this proxy statement.

The proposed Divestiture is entirely a corporate action. Our stockholders will not realize any gain or loss for U.S. federal income tax purposes as a result
of the Divestiture.

The proposed Divestiture will be treated as a sale of corporate stock in exchange for cash. We anticipate that our tax basis in our
Aadi Sub stock will not be less than the purchase price for the sale of the FYARRO Business, and accordingly, that we do not expect to realize gain on the sale of our Aadi Sub stock. Nevertheless, the determination of whether we will realize gain or
loss on the proposed Divestiture and (if applicable) whether and to what extent our tax attributes will be available to offset any gain is highly complex and is based in part upon facts that will not be known until the completion of the Divestiture
and the finalization of any purchase price adjustments associated with the Divestiture. Therefore, it is possible that we will incur U.S. federal income tax as a result of the proposed Divestiture.

We also expect that the portion of our consolidated net operating loss carryforwards (“NOLs”) and other tax attributes that are allocable to Aadi
Sub will generally remain with Aadi Sub and will no longer constitute tax attributes of Aadi following the Divestiture.

Regulatory Approvals Required for the Divestiture

General Efforts

Upon the terms and subject to the
conditions set forth in the Divestiture Agreement, Aadi and Kaken agreed to use commercially reasonable efforts to avoid or eliminate legal impediments so as to enable the completion of the Divestiture to occur as expeditiously as possible.

Appraisal Rights

No appraisal or dissenters’ rights
are available to Aadi stockholders under the DGCL or under Aadi’s certificate of incorporation or bylaws in connection with the Divestiture Agreement.

- 72 -

THE DIVESTITURE AGREEMENT

The following summary describes the material provisions of the Divestiture Agreement. The descriptions of the Divestiture Agreement in this summary and elsewhere in this proxy statement are not complete and are qualified in their entirety by reference to the Divestiture Agreement, a copy of which is attached to this proxy statement as Annex A and incorporated into this proxy statement by reference. We encourage you to carefully read and consider the Divestiture Agreement, which is the legal document that governs the Divestiture, in its entirety